UNINTENTIONAL MONOTHERAPY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB AND DRUG SURVIVAL RATE OF TOFACITINIB

Basit Öğe Kaydı
dc.contributor.authorInanc, N.
dc.contributor.authorAbacar, K.
dc.contributor.authorOzturk, M. A.
dc.contributor.authorTufan, A.
dc.contributor.authorKaradeniz, H.
dc.contributor.authorSari, I.
dc.contributor.authorOnen, F.
dc.date.accessioned2026-08-12T18:12:29Z
dc.date.issued2022
dc.departmentFırat Üniversitesi
dc.descriptionAnnual European Congress of Rheumatology (EULAR) -- JUN 01-04, 2022 -- Copenhagen, DENMARK
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipEuropean Alliance Assoc Rheumatol
dc.identifier.doi10.1136/annrheumdis-2022-eular.5102
dc.identifier.endpage1338
dc.identifier.issn0003-4967
dc.identifier.issn1468-2060
dc.identifier.orcid0000-0003-2167-4509
dc.identifier.orcid0000-0003-4995-430X
dc.identifier.orcid0000-0001-8347-0873
dc.identifier.startpage1338
dc.identifier.urihttps://doi.org/10.1136/annrheumdis-2022-eular.5102
dc.identifier.urihttps://hdl.handle.net/11508/63905
dc.identifier.volume81
dc.identifier.wosWOS:000850279005278
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofAnnals of the Rheumatic Diseases
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.titleUNINTENTIONAL MONOTHERAPY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB AND DRUG SURVIVAL RATE OF TOFACITINIB
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu